C. Sebban

Aortic pulse wave velocity as a marker of cardiovascular disease in subjects over 70 years old

Sylvie Meaume, A. Rudnichi, Antony Lynch et al. · Journal of Hypertension · 2001 · 129 citations

S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: II. Functional Profile in Comparison to Clozapine and Haloperidol

Mark J. Millan, Rudy Schreiber, Anne Dekeyne et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 87 citations

Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission

C. Sebban, X Q Zhang, B Tesolin‐Decros et al. · British Journal of Pharmacology · 1999 · 81 citations · Full text

Diurnal variations of EEG power in healthy adults

P. Cacot, B. Tesolin, C. Sebban · Electroencephalography and Clinical Neurophysiology · 1995 · 66 citations

Sleep, Neurophysiology, Eeg Signal Processing +5

Effects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA‐, α₁‐ and 5‐HT_2A‐receptors

C. Sebban, B Tesolin‐Decros, Jorge Ciprian‐Ollivier et al. · British Journal of Pharmacology · 2002 · 64 citations · Full text